|Bid||1.38 x 0|
|Ask||1.39 x 0|
|Day's Range||1.37 - 1.41|
|52 Week Range||1.05 - 2.79|
|Beta (3Y Monthly)||2.30|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||2.52|
VANCOUVER , Nov. 16, 2018 /CNW/ - Trading resumes in: Company: GTEC Holdings Ltd. TSX-Venture Symbol: GTEC Resumption (ET): 10:30 AM Company: Invictus MD Strategies Corp. TSX-Venture Symbol: GENE Resumption ...
VANCOUVER , Nov. 16, 2018 /CNW/ - The following issues have been halted by IIROC: Company: GTEC Holdings Inc. TSX-Venture Symbol: GTEC Reason: Pending Company Contact Halt Time (ET): 9:34 AM Company: Invictus ...
FRA: 8IS1) is pleased to announce that it has entered into a non-binding Letter of Intent (the "Agreement") with GTEC Holdings Ltd. (TSXV:GTEC.V - News) (OTC:GGTTF - News) ("GTEC") for the acquisition by Invictus of all of the issued and outstanding shares in the capital of GTEC in an all-share transaction valued at approximately $100 million (the "Transaction"), forming Western Canada's largest indoor vertically integrated cannabis companies. Under the terms of the proposed Transaction, which will be completed by way of a Plan of Arrangement, holders of GTEC common shares will receive approximately 40% of the issued and outstanding shares of Invictus post-closing.
The Delta Facility includes a cultivation, production and research facility, recently licensed under the Cannabis Act and Cannabis Regulations. The Mission Location includes 32 acres of buildable land, expandable up to 1 million square feet of production capacity under one Cannabis Act and Cannabis Regulations license.
TORONTO, Nov. 13, 2018 -- Today, New Green Frontier, an invite-only, cannabis investor conference, is pleased to announce that Gene Simmons, legendary rock star, Chief.
KELOWNA, BC , Nov. 9, 2018 /CNW/ - GTEC Holdings Ltd. (TSXV: GTEC) (OTC: GGTTF) (" GTEC " or the " Company ") is pleased to announce that its wholly owned subsidiary, Alberta Craft ...
FRA: 8IS1) and Poda Technologies Ltd. ("Poda") are pleased to announce the completion of the plan of arrangement to give effect to the spinout transaction (the "Arrangement"), as previously announced on August 21, 2018. The arrangement agreement between Invictus and Poda dated September 10, 2018, sets out the terms of the Arrangement. The Arrangement was voted on and approved by the Company's shareholders at its 2018 Annual General and Special Meeting of Shareholders, held on October 18, 2018.
Invictus is a global cannabis company offering a selection of products under a wide range of lifestyle brands. Invictus has partnered with business leaders to convey our corporate vision, including KISS music legend and business mogul Gene Simmons as our Chief Evangelist Officer. To meet growing demand, Invictus is expanding its cultivation footprint, with two cannabis production facilities fully licensed under ACMPR in Canada and a third awaiting approval, featuring 100,000 square feet of available grow space today with 200,000 expected by January 2019 and up to 1 million by end of 2020.
FRA: 8IS1) is pleased to announce that it has entered into a definitive agreement to acquire 100% (the "Acquisition") of the issued and outstanding shares of a company ("Leaf Wise") that operates medical clinics in Alberta (see press release dated July 20, 2018, for more details). Leaf Wise employs a patient-first business model that features on-site physicians, educational guides and registration support in just four easy steps. With approximately 3,400 patients registered under Access to Cannabis for Medical Purposes Regulations ("ACMPR"), Leaf Wise will serve as a direct channel to Invictus owned Licensed Producers ("LPs"), fully licensed under ACMPR.
OTC: GGTTF) ("GTEC") dated October 16, 2018, as announced on October 19, 2018, it has completed the advance of $2,000,000 of convertible debt (the "Convertible Debt"), evidenced by way of a Convertible Grid Promissory Note (the "Promissory Note"). The proceeds from the Convertible Debt will be used by GTEC to further execute GTEC's cannabis retail expansion strategy in Canada.
FRA: 8IS1) announces the following voting results from the Company's 2018 Annual General and Special Meeting of Shareholders (the "Meeting"), which was held in Vancouver on October 18, 2018. A total of 37,280,226 common shares of the 96,623,857 common shares outstanding at the record date were voted at the Meeting, representing 38.58% of the issued and outstanding common shares of the Company at the record date.
KELOWNA, BC, Oct. 19, 2018 /CNW/ - GTEC Holdings Ltd. (TSXV:GTEC.V - News) (OTCPK:GGTTF - News) ("GTEC" or the "Company") is pleased to announce that it has entered into a definitive agreement (the "Definitive Agreement") with Invictus MD Strategies Corp. (TSXV:GENE.V - News) (OTC:IVITF - News) (FRA:8IS1.F - News) for the previously announced non-revolving unsecured convertible loan (the "Loan Facility") in an amount up to $2,000,000, and an interest rate of 8% (see press release dated August 30, 2018, for more details). The proceeds from the Loan Facility will be used by GTEC for the expansion and development of its cannabis retail strategy in Canada.
OTCPK: GGTTF) for the previously announced non-revolving unsecured convertible loan (the "Loan Facility") in an amount up to $2,000,000, and an interest rate of 8% (see press release dated August 30, 2018, for more details). The proceeds from the Loan Facility will be used by GTEC for the expansion and development of its cannabis retail strategy in Canada.
FRA: 8IS1) announces the completion of its previously announced bought deal offering of units ("Units") pursuant to a short form prospectus through PI Financial Corp. and GMP Securities L.P. as co-lead underwriters, Canaccord Genuity Corp. and Echelon Wealth Partners Inc. (the "Underwriters") and the exercise in full of the over-allotment option granted to the Underwriters to purchase an additional 1,500,000 Units (the "Offering"). In connection with the Offering, the Company issued an aggregate of 11,500,000 Units at a price of C$2.00 per Unit for gross proceeds of C$23,000,000. Each Unit consists of one common share of the Company and one-half of one transferable common share purchase warrant (each whole common share purchase warrant, a "Warrant"). Each Warrant is exercisable to purchase one common share of the Company at an exercise price of C$2.40 on or before October 19, 2020.
The Company now has 30 days to exercise its option (the "Option") under the Definitive Option Agreement (the "Definitive Option Agreement") (see press releases dated May 16, 2018 and July 18, 2018 for more details). If the Option is exercised, it will represent the Company's third cultivation facility licensed by Health Canada under the ACMPR.
Wayland Group (CSE:WAYL) (75M.F) (MRRCF) (“Wayland” or the “Company”) wishes to make the following statements regarding recent market activity in its common shares traded on the OTCQB marketplace. The Company has been asked to issue this release by OTC Markets to comment on certain continued promotional activities beginning on or around October 1, 2018. The Company became aware of certain continued promotional activity relating to its securities on October 8, 2018 upon receipt of correspondence from OTC Markets specifically related to certain promotional literature encouraging investors to purchase the Company's common shares and making certain statements regarding the potential returns on such investment, including certain promotional newsletter emails.
KELOWNA, BC, Oct. 11, 2018 /CNW/ - GTEC Holdings Ltd. (TSXV:GTEC.V - News) (OTCPK:GGTTF - News) ("GTEC" or the "Company") is pleased to provide the following updates on its retail operations. Cannabis Cowboy has currently received 10 development permits from their respective municipalities in Alberta, which include locations in Calgary, Red Deer, and Lethbridge. Cannabis Cowboy expects to have 11 retail locations opened and operational in Q4 2018, with an additional 14 locations to be opened in Q1 2019.
FRA: 8IS1) is pleased to announce that the Company's Chairman and CEO, Dan Kriznic, will be presenting at Cannabis Invest, the UK and Europe's leading cannabis investment conference, in London on October 2, 2018, and in Geneva on October 3, 2018. Invictus has also granted 160,000 incentive stock options to certain eligible persons of the Company. Each stock option has an exercise price equal to today's closing price and is exercisable into one common share of the Company.
FRA: 8IS1) announces that it has entered into an agreement with PI Financial Corp. and GMP Securities L.P. as co-lead underwriters on behalf of a syndicate of underwriters (the "Underwriters"), pursuant to which the Underwriters have agreed to purchase, on a bought deal basis pursuant to a short form prospectus, 10,000,000 units (the "Units") of the Company at a price of C$2.00 per Unit (the "Offering Price") for gross proceeds of C$20,000,000 (the "Underwritten Offering"). In connection with the Offering, Eventus Capital Corp. has been appointed as a special advisor to the Company.
FRA: 8IS1) is pleased to have completed its first shipment of recreational cannabis to British Columbia on time, following its inaugural shipment to Alberta. This significant milestone was made possible by the Company's balanced and deliberate approach towards cultivation and regulatory compliance. "I am so proud of what our team has accomplished to date," said Dan Kriznic, Invictus Chairman and CEO.
FRA: 8IS1) is pleased to announce the addition of former Heineken executive Kevin Smith as Vice President Recreational Sales, commencing October 1, 2018, and Sarah Hardy, MBA, as Vice President Medical Sales, effective August 20, 2018.
VANCOUVER, Sept. 11, 2018 /CNW/ - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV:GENE.V - News) (OTCQX:IVITF - News) (FRA:8IS1.F - News) is pleased to announce that its wholly-owned subsidiary, Acreage Pharms Ltd. ("Acreage Pharms"), has been granted conditional approval to become a registered supplier with the Saskatchewan Liquor and Gaming Authority ("SLGA") once legislation is implemented on October 17, 2018. In the interim, and subject to any federal restrictions, Acreage Pharms is eligible to supply product to authorized provincial wholesalers and retailers in advance of October 17. "We are thrilled to become a registered supplier in Saskatchewan, our third provincial agreement behind British Columbia and Alberta," said Dan Kriznic CEO and Chairman for Invictus.
FRA: 8IS1) announced today that it has entered into a non-arm's length arrangement agreement dated September 10, 2018 (the "Agreement"), with Poda Technologies Inc. ("Poda") to give effect to the spin-out transaction previously announced on August 21, 2018.
FRA: 8IS1) is pleased to have completed its first shipment of recreational cannabis under Provincial supply agreement on schedule, ensuring quality product for opening day on October 17, 2018. "The cannabis industry is moving rapidly to ramp-up production and deliver a steady supply of product to the recreational market in Canada," said Dan Kriznic, Chairman and CEO of Invictus. To date, Invictus' wholly-owned subsidiary Acreage Pharms has secured provincial supply agreements for the upcoming adult recreational markets in both British Columbia and Alberta, while actively pursuing supply agreements in other provinces.
FRA: 8IS1) is pleased to announce that it has closed the previously disclosed $25.5 million debt financing arrangement (the "Financing") with ATB Financial ("ATB") (see press release dated August 8, 2018, for further details). The Financing will be used to accelerate the construction of its Phase 3 and Phase 4 cannabis cultivation facilities (the "Expansion Plan") at Acreage Pharms Ltd. ("Acreage Pharms"), located in West-Central Alberta. The Expansion Plan will add a total of 180,000 square feet of production capacity to Acreage Pharms.